tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market

Ovid Therapeutics (OVID) Income Statement

Compare
1,322 Followers

Ovid Therapeutics Income Statement

Last quarter (Q3 2024), Ovid Therapeutics's total revenue was $173.00K, an increase of 58.76% from the same quarter last year. In Q3, Ovid Therapeutics's net income was $-14.01M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 391.69K$ 1.50M$ 208.38M$ 12.62M$ 0.00
Gross Profit
$ 391.69K$ 121.14K$ 208.38M$ 12.62M$ -255.00K
Operating Expenses
$ 59.67M$ 57.05M$ 84.17M$ 94.05M$ 61.41M
Depreciation and Amortization
$ 1.60M$ 1.38M$ 237.00K$ 307.00K$ 255.00K
EBITDA
$ -57.69M$ -52.79M$ 124.40M$ -81.12M$ -60.21M
Operating Income
$ -59.28M$ -55.55M$ 124.21M$ -81.43M$ -61.41M
Other Income/Expenses
$ 6.94M$ 1.38M$ -45.69K$ 395.40K$ 948.22K
Pretax Income
$ -52.34M$ -54.17M$ 124.16M$ -81.04M$ -60.46M
Net Income
$ -52.34M$ -51.41M$ 122.83M$ -80.73M$ -59.26M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.74$ -0.73$ 1.78$ -1.38$ -1.51
Diluted EPS
$ -0.74$ -0.73$ 1.78$ -1.38$ -1.51
Weighted Average Shares Outstanding
70.58M 70.42M 67.48M 58.45M 39.22M
Weighted Average Shares Outstanding (Diluted)
70.58M 70.42M 68.07M 58.45M 39.22M
Currency in USD

Ovid Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis